ID   PDK2_HUMAN              Reviewed;         407 AA.
AC   Q15119; A8K3A7; B3KNW0; Q6P515; Q9BS05;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   06-JUN-2002, sequence version 2.
DT   12-OCT-2022, entry version 202.
DE   RecName: Full=[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial;
DE            EC=2.7.11.2;
DE   AltName: Full=Pyruvate dehydrogenase kinase isoform 2;
DE            Short=PDH kinase 2;
DE            Short=PDKII;
DE   Flags: Precursor;
GN   Name=PDK2; Synonyms=PDHK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=7499431; DOI=10.1074/jbc.270.48.28989;
RA   Gudi R., Bowker-Kinley M.M., Kedishvili N.Y., Zhao Y., Popov K.M.;
RT   "Diversity of the pyruvate dehydrogenase kinase gene family in humans.";
RL   J. Biol. Chem. 270:28989-28994(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ARG-342.
RC   TISSUE=Lung, Prostate, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INDUCTION BY INSULIN, AND FUNCTION.
RX   PubMed=9787110; DOI=10.1006/mgme.1998.2748;
RA   Majer M., Popov K.M., Harris R.A., Bogardus C., Prochazka M.;
RT   "Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential
RT   mechanism contributing to increased lipid oxidation in insulin-resistant
RT   subjects.";
RL   Mol. Genet. Metab. 65:181-186(1998).
RN   [7]
RP   SUBUNIT, AND INTERACTION WITH DLAT.
RX   PubMed=12816949; DOI=10.1074/jbc.m212733200;
RA   Hiromasa Y., Roche T.E.;
RT   "Facilitated interaction between the pyruvate dehydrogenase kinase isoform
RT   2 and the dihydrolipoyl acetyltransferase.";
RL   J. Biol. Chem. 278:33681-33693(2003).
RN   [8]
RP   CATALYTIC ACTIVITY, SUBUNIT, AND ACTIVITY REGULATION.
RX   PubMed=15491150; DOI=10.1021/bi049488x;
RA   Bao H., Kasten S.A., Yan X., Roche T.E.;
RT   "Pyruvate dehydrogenase kinase isoform 2 activity limited and further
RT   inhibited by slowing down the rate of dissociation of ADP.";
RL   Biochemistry 43:13432-13441(2004).
RN   [9]
RP   CATALYTIC ACTIVITY, INTERACTION WITH DLAT, SUBUNIT, AND ACTIVITY
RP   REGULATION.
RX   PubMed=16517984; DOI=10.1074/jbc.m513514200;
RA   Hiromasa Y., Hu L., Roche T.E.;
RT   "Ligand-induced effects on pyruvate dehydrogenase kinase isoform 2.";
RL   J. Biol. Chem. 281:12568-12579(2006).
RN   [10]
RP   FUNCTION.
RX   PubMed=17222789; DOI=10.1016/j.ccr.2006.10.020;
RA   Bonnet S., Archer S.L., Allalunis-Turner J., Haromy A., Beaulieu C.,
RA   Thompson R., Lee C.T., Lopaschuk G.D., Puttagunta L., Bonnet S., Harry G.,
RA   Hashimoto K., Porter C.J., Andrade M.A., Thebaud B., Michelakis E.D.;
RT   "A mitochondria-K+ channel axis is suppressed in cancer and its
RT   normalization promotes apoptosis and inhibits cancer growth.";
RL   Cancer Cell 11:37-51(2007).
RN   [11]
RP   INDUCTION BY PPARD.
RX   PubMed=17669420; DOI=10.1016/j.jmb.2007.06.091;
RA   Degenhardt T., Saramaki A., Malinen M., Rieck M., Vaisanen S., Huotari A.,
RA   Herzig K.H., Muller R., Carlberg C.;
RT   "Three members of the human pyruvate dehydrogenase kinase gene family are
RT   direct targets of the peroxisome proliferator-activated receptor
RT   beta/delta.";
RL   J. Mol. Biol. 372:341-355(2007).
RN   [12]
RP   CATALYTIC ACTIVITY, FUNCTION, ACTIVITY REGULATION, INTERACTION WITH DLAT,
RP   AND SUBUNIT.
RX   PubMed=19833728; DOI=10.1074/jbc.m109.065557;
RA   Li J., Kato M., Chuang D.T.;
RT   "Pivotal role of the C-terminal DW-motif in mediating inhibition of
RT   pyruvate dehydrogenase kinase 2 by dichloroacetate.";
RL   J. Biol. Chem. 284:34458-34467(2009).
RN   [13]
RP   FUNCTION, AND INDUCTION BY CIGARETTE SMOKE EXTRACT AND REACTIVE OXYGEN
RP   SPECIES.
RX   PubMed=21283817; DOI=10.1371/journal.pone.0016207;
RA   Sun W., Chang S.S., Fu Y., Liu Y., Califano J.A.;
RT   "Chronic CSE treatment induces the growth of normal oral keratinocytes via
RT   PDK2 upregulation, increased glycolysis and HIF1alpha stabilization.";
RL   PLoS ONE 6:E16207-E16207(2011).
RN   [14]
RP   FUNCTION.
RX   PubMed=22123926; DOI=10.1158/0008-5472.can-11-1215;
RA   Contractor T., Harris C.R.;
RT   "p53 negatively regulates transcription of the pyruvate dehydrogenase
RT   kinase Pdk2.";
RL   Cancer Res. 72:560-567(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 16-407 IN COMPLEX WITH ATP AND THE
RP   INHIBITORS AZD7545; NOV3R; PFZ3 AND DICHLOROACETATE.
RX   PubMed=16401071; DOI=10.1021/bi051402s;
RA   Knoechel T.R., Tucker A.D., Robinson C.M., Phillips C., Taylor W.,
RA   Bungay P.J., Kasten S.A., Roche T.E., Brown D.G.;
RT   "Regulatory roles of the N-terminal domain based on crystal structures of
RT   human pyruvate dehydrogenase kinase 2 containing physiological and
RT   synthetic ligands.";
RL   Biochemistry 45:402-415(2006).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-342.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Kinase that plays a key role in the regulation of glucose and
CC       fatty acid metabolism and homeostasis via phosphorylation of the
CC       pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvate
CC       dehydrogenase activity, and thereby regulates metabolite flux through
CC       the tricarboxylic acid cycle, down-regulates aerobic respiration and
CC       inhibits the formation of acetyl-coenzyme A from pyruvate. Inhibition
CC       of pyruvate dehydrogenase decreases glucose utilization and increases
CC       fat metabolism. Mediates cellular responses to insulin. Plays an
CC       important role in maintaining normal blood glucose levels and in
CC       metabolic adaptation to nutrient availability. Via its regulation of
CC       pyruvate dehydrogenase activity, plays an important role in maintaining
CC       normal blood pH and in preventing the accumulation of ketone bodies
CC       under starvation. Plays a role in the regulation of cell proliferation
CC       and in resistance to apoptosis under oxidative stress. Plays a role in
CC       p53/TP53-mediated apoptosis. {ECO:0000269|PubMed:17222789,
CC       ECO:0000269|PubMed:19833728, ECO:0000269|PubMed:21283817,
CC       ECO:0000269|PubMed:22123926, ECO:0000269|PubMed:7499431,
CC       ECO:0000269|PubMed:9787110}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[pyruvate dehydrogenase E1 alpha subunit] = ADP
CC         + H(+) + O-phospho-L-seryl-[pyruvate dehydrogenase E1 alpha subunit];
CC         Xref=Rhea:RHEA:23052, Rhea:RHEA-COMP:13689, Rhea:RHEA-COMP:13690,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.2;
CC         Evidence={ECO:0000269|PubMed:15491150, ECO:0000269|PubMed:16517984,
CC         ECO:0000269|PubMed:19833728, ECO:0000269|PubMed:7499431};
CC   -!- ACTIVITY REGULATION: Activity is enhanced by binding to the pyruvate
CC       dehydrogenase subunit DLAT. Inhibited by ADP and pyruvate; these
CC       compounds interfere with DLAT binding and thereby inhibit kinase
CC       activity. Inhibited by dichloroacetate. Inhibited by AZD7545; this
CC       compound interferes with DLAT binding and thereby inhibits kinase
CC       activity. {ECO:0000269|PubMed:15491150, ECO:0000269|PubMed:16517984,
CC       ECO:0000269|PubMed:19833728}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with PDK1. Interacts with the
CC       pyruvate dehydrogenase complex subunit DLAT, and is part of the
CC       multimeric pyruvate dehydrogenase complex that contains multiple copies
CC       of pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase
CC       (DLAT, E2) and lipoamide dehydrogenase (DLD, E3).
CC       {ECO:0000269|PubMed:12816949, ECO:0000269|PubMed:15491150,
CC       ECO:0000269|PubMed:16401071, ECO:0000269|PubMed:16517984,
CC       ECO:0000269|PubMed:19833728}.
CC   -!- INTERACTION:
CC       Q15119; P42858: HTT; NbExp=10; IntAct=EBI-726271, EBI-466029;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15119-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15119-2; Sequence=VSP_042549;
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues, with the highest level
CC       in heart and skeletal muscle, intermediate levels in brain, kidney,
CC       pancreas and liver, and low levels in placenta and lung.
CC       {ECO:0000269|PubMed:7499431}.
CC   -!- INDUCTION: Down-regulated by insulin. Up-regulated by reactive oxygen
CC       species and cigarette smoke extract. Up-regulated by PPARD.
CC       {ECO:0000269|PubMed:17669420, ECO:0000269|PubMed:21283817,
CC       ECO:0000269|PubMed:9787110}.
CC   -!- SIMILARITY: Belongs to the PDK/BCKDK protein kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L42451; AAC42010.1; -; mRNA.
DR   EMBL; AK055119; BAG51472.1; -; mRNA.
DR   EMBL; AK290522; BAF83211.1; -; mRNA.
DR   EMBL; AC002401; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94642.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94644.1; -; Genomic_DNA.
DR   EMBL; BC005811; AAH05811.1; -; mRNA.
DR   EMBL; BC040478; AAH40478.1; -; mRNA.
DR   EMBL; BC063137; AAH63137.1; -; mRNA.
DR   CCDS; CCDS11559.1; -. [Q15119-1]
DR   CCDS; CCDS56039.1; -. [Q15119-2]
DR   PIR; I70159; I70159.
DR   RefSeq; NP_001186827.1; NM_001199898.1. [Q15119-2]
DR   RefSeq; NP_001186828.1; NM_001199899.1. [Q15119-2]
DR   RefSeq; NP_002602.2; NM_002611.4. [Q15119-1]
DR   PDB; 2BTZ; X-ray; 2.20 A; A=16-407.
DR   PDB; 2BU2; X-ray; 2.40 A; A=16-407.
DR   PDB; 2BU5; X-ray; 2.35 A; A=16-407.
DR   PDB; 2BU6; X-ray; 2.40 A; A=16-407.
DR   PDB; 2BU7; X-ray; 2.40 A; A=16-407.
DR   PDB; 2BU8; X-ray; 2.50 A; A=16-407.
DR   PDB; 4MP2; X-ray; 1.75 A; A=9-407.
DR   PDB; 4MP7; X-ray; 1.80 A; A=9-407.
DR   PDB; 4MPC; X-ray; 1.70 A; A=9-407.
DR   PDB; 4MPE; X-ray; 1.95 A; A=9-407.
DR   PDB; 4MPN; X-ray; 1.75 A; A=9-407.
DR   PDB; 4V25; X-ray; 2.60 A; A=1-407.
DR   PDB; 4V26; X-ray; 2.49 A; A=1-407.
DR   PDB; 5J6A; X-ray; 2.04 A; A=9-407.
DR   PDB; 5J71; X-ray; 1.65 A; A=9-407.
DR   PDB; 5M4K; X-ray; 2.60 A; A=1-407.
DR   PDB; 5M4M; X-ray; 2.40 A; A=1-407.
DR   PDB; 5M4N; X-ray; 2.60 A; A=1-407.
DR   PDB; 5M4P; X-ray; 2.30 A; A=1-407.
DR   PDB; 6LIL; X-ray; 1.93 A; A/B=6-386.
DR   PDB; 6LIN; X-ray; 2.67 A; A/B/C/D=6-386.
DR   PDB; 6LIO; X-ray; 1.76 A; A/B=6-386.
DR   PDB; 6TMP; X-ray; 2.08 A; AAA=14-407.
DR   PDB; 6TMQ; X-ray; 2.11 A; AAA=14-407.
DR   PDB; 6TMZ; X-ray; 2.71 A; AAA=14-407.
DR   PDB; 6TN0; X-ray; 1.91 A; AAA=14-407.
DR   PDB; 6TN2; X-ray; 1.77 A; AAA=14-407.
DR   PDB; 7EA0; X-ray; 2.34 A; A=16-407.
DR   PDB; 7EAS; X-ray; 1.97 A; A=16-407.
DR   PDB; 7EBH; X-ray; 1.96 A; A=16-407.
DR   PDB; 7VBU; X-ray; 1.89 A; A=16-407.
DR   PDB; 7VBV; X-ray; 2.21 A; A/B=16-407.
DR   PDB; 7VBX; X-ray; 2.60 A; A=16-407.
DR   PDBsum; 2BTZ; -.
DR   PDBsum; 2BU2; -.
DR   PDBsum; 2BU5; -.
DR   PDBsum; 2BU6; -.
DR   PDBsum; 2BU7; -.
DR   PDBsum; 2BU8; -.
DR   PDBsum; 4MP2; -.
DR   PDBsum; 4MP7; -.
DR   PDBsum; 4MPC; -.
DR   PDBsum; 4MPE; -.
DR   PDBsum; 4MPN; -.
DR   PDBsum; 4V25; -.
DR   PDBsum; 4V26; -.
DR   PDBsum; 5J6A; -.
DR   PDBsum; 5J71; -.
DR   PDBsum; 5M4K; -.
DR   PDBsum; 5M4M; -.
DR   PDBsum; 5M4N; -.
DR   PDBsum; 5M4P; -.
DR   PDBsum; 6LIL; -.
DR   PDBsum; 6LIN; -.
DR   PDBsum; 6LIO; -.
DR   PDBsum; 6TMP; -.
DR   PDBsum; 6TMQ; -.
DR   PDBsum; 6TMZ; -.
DR   PDBsum; 6TN0; -.
DR   PDBsum; 6TN2; -.
DR   PDBsum; 7EA0; -.
DR   PDBsum; 7EAS; -.
DR   PDBsum; 7EBH; -.
DR   PDBsum; 7VBU; -.
DR   PDBsum; 7VBV; -.
DR   PDBsum; 7VBX; -.
DR   AlphaFoldDB; Q15119; -.
DR   SMR; Q15119; -.
DR   BioGRID; 111190; 27.
DR   IntAct; Q15119; 27.
DR   MINT; Q15119; -.
DR   STRING; 9606.ENSP00000420927; -.
DR   BindingDB; Q15119; -.
DR   ChEMBL; CHEMBL3861; -.
DR   DrugBank; DB08609; (2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide.
DR   DrugBank; DB08608; 4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE.
DR   DrugBank; DB08610; N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE.
DR   DrugCentral; Q15119; -.
DR   GuidetoPHARMACOLOGY; 2142; -.
DR   iPTMnet; Q15119; -.
DR   PhosphoSitePlus; Q15119; -.
DR   BioMuta; PDK2; -.
DR   DMDM; 21431820; -.
DR   EPD; Q15119; -.
DR   jPOST; Q15119; -.
DR   MassIVE; Q15119; -.
DR   MaxQB; Q15119; -.
DR   PaxDb; Q15119; -.
DR   PeptideAtlas; Q15119; -.
DR   PRIDE; Q15119; -.
DR   ProteomicsDB; 60445; -. [Q15119-1]
DR   ProteomicsDB; 60446; -. [Q15119-2]
DR   Antibodypedia; 1630; 549 antibodies from 34 providers.
DR   DNASU; 5164; -.
DR   Ensembl; ENST00000007708.7; ENSP00000007708.3; ENSG00000005882.12. [Q15119-2]
DR   Ensembl; ENST00000503176.6; ENSP00000420927.1; ENSG00000005882.12. [Q15119-1]
DR   Ensembl; ENST00000614357.4; ENSP00000481915.1; ENSG00000005882.12. [Q15119-2]
DR   GeneID; 5164; -.
DR   KEGG; hsa:5164; -.
DR   MANE-Select; ENST00000503176.6; ENSP00000420927.1; NM_002611.5; NP_002602.2.
DR   UCSC; uc002iqb.4; human. [Q15119-1]
DR   CTD; 5164; -.
DR   DisGeNET; 5164; -.
DR   GeneCards; PDK2; -.
DR   HGNC; HGNC:8810; PDK2.
DR   HPA; ENSG00000005882; Tissue enhanced (skeletal muscle, tongue).
DR   MIM; 602525; gene.
DR   neXtProt; NX_Q15119; -.
DR   OpenTargets; ENSG00000005882; -.
DR   PharmGKB; PA33155; -.
DR   VEuPathDB; HostDB:ENSG00000005882; -.
DR   eggNOG; KOG0787; Eukaryota.
DR   GeneTree; ENSGT01030000234646; -.
DR   HOGENOM; CLU_023861_1_1_1; -.
DR   InParanoid; Q15119; -.
DR   OMA; APQIGDH; -.
DR   OrthoDB; 1242599at2759; -.
DR   PhylomeDB; Q15119; -.
DR   TreeFam; TF314918; -.
DR   BRENDA; 2.7.11.2; 2681.
DR   PathwayCommons; Q15119; -.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   SignaLink; Q15119; -.
DR   SIGNOR; Q15119; -.
DR   BioGRID-ORCS; 5164; 60 hits in 1107 CRISPR screens.
DR   ChiTaRS; PDK2; human.
DR   EvolutionaryTrace; Q15119; -.
DR   GeneWiki; PDK2; -.
DR   GenomeRNAi; 5164; -.
DR   Pharos; Q15119; Tchem.
DR   PRO; PR:Q15119; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q15119; protein.
DR   Bgee; ENSG00000005882; Expressed in hindlimb stylopod muscle and 187 other tissues.
DR   ExpressionAtlas; Q15119; baseline and differential.
DR   Genevisible; Q15119; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005967; C:mitochondrial pyruvate dehydrogenase complex; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; IDA:UniProtKB.
DR   GO; GO:0031670; P:cellular response to nutrient; ISS:UniProtKB.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IMP:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:ProtInc.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; ISS:UniProtKB.
DR   GO; GO:0050848; P:regulation of calcium-mediated signaling; IEA:Ensembl.
DR   GO; GO:0010565; P:regulation of cellular ketone metabolic process; ISS:UniProtKB.
DR   GO; GO:0006111; P:regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; ISS:UniProtKB.
DR   GO; GO:0006885; P:regulation of pH; ISS:UniProtKB.
DR   Gene3D; 1.20.140.20; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR036784; AK/P_DHK_N_sf.
DR   InterPro; IPR018955; BCDHK/PDK_N.
DR   InterPro; IPR039028; BCKD/PDK.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR005467; His_kinase_dom.
DR   PANTHER; PTHR11947; PTHR11947; 1.
DR   Pfam; PF10436; BCDHK_Adom3; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   SUPFAM; SSF69012; SSF69012; 1.
DR   PROSITE; PS50109; HIS_KIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Carbohydrate metabolism;
KW   Glucose metabolism; Kinase; Mitochondrion; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..?
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           ?..407
FT                   /note="[Pyruvate dehydrogenase (acetyl-transferring)]
FT                   kinase isozyme 2, mitochondrial"
FT                   /id="PRO_0000023440"
FT   DOMAIN          135..364
FT                   /note="Histidine kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00107"
FT   BINDING         251..258
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:16401071"
FT   BINDING         290
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:16401071"
FT   BINDING         309..310
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         325..330
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:16401071"
FT   MOD_RES         215
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15118"
FT   MOD_RES         216
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15118"
FT   MOD_RES         376
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BFP9"
FT   VAR_SEQ         1..64
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042549"
FT   VARIANT         342
FT                   /note="G -> R (in a glioblastoma multiforme sample; somatic
FT                   mutation; dbSNP:rs17855787)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042296"
FT   CONFLICT        80
FT                   /note="S -> T (in Ref. 1; AAC42010)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        407
FT                   /note="S -> T (in Ref. 1; AAC42010)"
FT                   /evidence="ECO:0000305"
FT   HELIX           6..12
FT                   /evidence="ECO:0007829|PDB:6LIN"
FT   HELIX           13..15
FT                   /evidence="ECO:0007829|PDB:5J6A"
FT   HELIX           16..24
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           33..37
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           43..45
FT                   /evidence="ECO:0007829|PDB:7VBU"
FT   HELIX           46..68
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           73..76
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           79..96
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   TURN            97..100
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:5M4K"
FT   HELIX           106..122
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   TURN            123..125
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           126..141
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           145..175
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   STRAND          177..179
FT                   /evidence="ECO:0007829|PDB:2BU8"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:6LIL"
FT   STRAND          191..196
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           197..216
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   STRAND          222..230
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   STRAND          237..240
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           242..262
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   TURN            263..266
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   STRAND          267..269
FT                   /evidence="ECO:0007829|PDB:6LIO"
FT   STRAND          273..279
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   STRAND          281..290
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           297..299
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           301..304
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   TURN            306..309
FT                   /evidence="ECO:0007829|PDB:4MPC"
FT   HELIX           323..325
FT                   /evidence="ECO:0007829|PDB:4V26"
FT   STRAND          326..328
FT                   /evidence="ECO:0007829|PDB:5M4P"
FT   HELIX           329..339
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   STRAND          343..349
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   TURN            350..352
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   STRAND          353..363
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   TURN            364..366
FT                   /evidence="ECO:0007829|PDB:5J71"
FT   HELIX           376..381
FT                   /evidence="ECO:0007829|PDB:5J71"
SQ   SEQUENCE   407 AA;  46154 MW;  77DBA03EF922EF03 CRC64;
     MRWVWALLKN ASLAGAPKYI EHFSKFSPSP LSMKQFLDFG SSNACEKTSF TFLRQELPVR
     LANIMKEINL LPDRVLSTPS VQLVQSWYVQ SLLDIMEFLD KDPEDHRTLS QFTDALVTIR
     NRHNDVVPTM AQGVLEYKDT YGDDPVSNQN IQYFLDRFYL SRISIRMLIN QHTLIFDGST
     NPAHPKHIGS IDPNCNVSEV VKDAYDMAKL LCDKYYMASP DLEIQEINAA NSKQPIHMVY
     VPSHLYHMLF ELFKNAMRAT VESHESSLIL PPIKVMVALG EEDLSIKMSD RGGGVPLRKI
     ERLFSYMYST APTPQPGTGG TPLAGFGYGL PISRLYAKYF QGDLQLFSME GFGTDAVIYL
     KALSTDSVER LPVYNKSAWR HYQTIQEAGD WCVPSTEPKN TSTYRVS
//
